| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |